Pages that link to "Q79317975"

The following pages link to Effect of dietary restraint during and following pegylated recombinant leptin (PEG-OB) treatment of overweight men (Q79317975):

Displaying 15 items.

• Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity (Q30592302) (← links)
• Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications (Q33998979) (← links)
• Leptin in human physiology and therapeutics (Q34047024) (← links)
• Agile delivery of protein therapeutics to CNS (Q34079647) (← links)
• Leptin in human physiology and pathophysiology. (Q35321788) (← links)
• Set points, settling points and some alternative models: theoretical options to understand how genes and environments combine to regulate body adiposity (Q35532343) (← links)
• 20 years of leptin: role of leptin in energy homeostasis in humans (Q35679798) (← links)
• Differential associations of leptin with adiposity across early childhood (Q36859602) (← links)
• Does behavioral intervention in pregnancy reduce postpartum weight retention? Twelve-month outcomes of the Fit for Delivery randomized trial (Q37486374) (← links)
• Sensitivity of ob/ob mice to leptin-induced adipose tissue apoptosis. (Q38319970) (← links)
• Psychobehavioral and nutritional predictors of weight loss in obese women treated with sibutramine (Q45176965) (← links)
• Effect of orlistat on eating behavior among participants in a 3-year weight maintenance trial. (Q46779241) (← links)
• The role of leptin in health and disease (Q49862904) (← links)
• Effect of high-fat meals and fatty acid saturation on postprandial levels of the hormones ghrelin and leptin in healthy men. (Q51511966) (← links)
• Leptin alters energy intake and fat mass but not energy expenditure in lean subjects (Q100533662) (← links)